Your browser doesn't support javascript.
loading
Cancer Stem-like Cells Act via Distinct Signaling Pathways in Promoting Late Stages of Malignant Progression.
da Silva-Diz, Victoria; Simón-Extremera, Pilar; Bernat-Peguera, Adrià; de Sostoa, Jana; Urpí, Maria; Penín, Rosa M; Sidelnikova, Diana Pérez; Bermejo, Oriol; Viñals, Joan Maria; Rodolosse, Annie; González-Suárez, Eva; Moruno, Antonio Gómez; Pujana, Miguel Ángel; Esteller, Manel; Villanueva, Alberto; Viñals, Francesc; Muñoz, Purificación.
Afiliação
  • da Silva-Diz V; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Simón-Extremera P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Bernat-Peguera A; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • de Sostoa J; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Urpí M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Penín RM; Pathology Service, Hospital Universitario de Bellvitge/IDIBELL, Barcelona, Spain.
  • Sidelnikova DP; Plastic Surgery Unit, Hospital Universitario de Bellvitge/IDIBELL, Barcelona, Spain.
  • Bermejo O; Plastic Surgery Unit, Hospital Universitario de Bellvitge/IDIBELL, Barcelona, Spain.
  • Viñals JM; Plastic Surgery Unit, Hospital Universitario de Bellvitge/IDIBELL, Barcelona, Spain.
  • Rodolosse A; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.
  • González-Suárez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Moruno AG; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Pujana MÁ; Laboratory of Translational Research, Catalan Institute of Oncology (ICO/IDIBELL), Barcelona, Spain.
  • Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. Unitat de Bioquímica i Biologia Molecular, Departament de Ciències Fisiològiques II, Universitat de Barcelona-IDIBELL, Barcelona, Spain. Institució Catalana de Recerca i Estudis Avança
  • Villanueva A; Laboratory of Translational Research, Catalan Institute of Oncology (ICO/IDIBELL), Barcelona, Spain.
  • Viñals F; Laboratory of Translational Research, Catalan Institute of Oncology (ICO/IDIBELL), Barcelona, Spain. Unitat de Bioquímica i Biologia Molecular, Departament de Ciències Fisiològiques II, Universitat de Barcelona-IDIBELL, Barcelona, Spain.
  • Muñoz P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. p.munoz@idibell.cat.
Cancer Res ; 76(5): 1245-59, 2016 Mar 01.
Article em En | MEDLINE | ID: mdl-26719534
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Células-Tronco Neoplásicas / Carcinoma de Células Escamosas / Transdução de Sinais Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Células-Tronco Neoplásicas / Carcinoma de Células Escamosas / Transdução de Sinais Idioma: En Ano de publicação: 2016 Tipo de documento: Article